A Phase I, Single Centre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of AZD8075 in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2010
At a glance
- Drugs AZD 8075 (Primary)
- Indications Asthma
- Focus Adverse reactions
- 01 Dec 2010 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 18 Apr 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 12 Nov 2008 New trial record.